Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders
Authors:
- 8 May 2008
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 15 (6) , 584-588
Abstract
Background: Gelsolin is a highly conserved intracellular actin‐binding protein with an extracellular isoform, plasma gelsolin, for which there is not yet a clearly defined function. Materials and methods: In this study, we determined gelsolin concentrations in blood and cerebrospinal fluid (CSF) obtained from 25 subjects using immunoblotting and a functional assay that quantifies gelsolin’s ability to accelerate actin polymerization. Results: The gelsolin concentration in CSF, determined by quantitative immunoblotting was 1.2–15.9 μg/ml (average 5.9 ± 3.8 μg/ml). In samples obtained from patients diagnosed with conditions that do not alter standard CSF clinical tests [(idiopathic cephalgia, ischialgia due to discopathy, and idiopathic (Bell’s) facial nerve palsy or entrapment radial neuropathy)], the average gelsolin concentration was 7.2 ± 4.3 μg/ml. In contrast, the gelsolin concentration in samples obtained from patients diagnosed with multiple sclerosis was 2.1 ± 0.7 μg/ml, and a similar low concentration was found in a patient recovering from a subarachnoid hemorrhage. The range of CSF gelsolin concentrations determined by the actin polymerization assay was 0.61–9.97 μg/ml (average 3.6 ± 2.2 μg/ml). These lower values compared with those obtained from immunoblotting analysis suggest that CSF gelsolin may bind other CSF molecules leading to a reduction of its actin‐binding activity. Conclusions: The results presented here show that CSF gelsolin concentration is significantly altered in certain neurological conditions, including multiple sclerosis, indicating the possible utility of CSF gelsolin levels for diagnostic purposes.Keywords
This publication has 34 references indexed in Scilit:
- Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolinAmerican Journal of Physiology-Cell Physiology, 2007
- Plasma gelsolin is a marker and therapeutic agent in animal sepsis*Critical Care Medicine, 2007
- Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mappingProteomics, 2006
- Inactivation of Endotoxin by Human Plasma GelsolinBiochemistry, 2005
- Proteomic analysis of cerebrospinal fluid from multiple sclerosis patientsProteomics, 2004
- Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantationBlood, 2002
- Gelsolin Binding and Cellular Presentation of Lysophosphatidic AcidJournal of Biological Chemistry, 2000
- Effects of semi-dilute actin solutions on the mobility of fibrin protofibrils during clot formationBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Plasma gelsolin caps and severs actin filamentsFEBS Letters, 1984
- Rating neurologic impairment in multiple sclerosisNeurology, 1983